Fig. 1From: Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from ChinaProgression free survival (A) and overall survival time (B) in HIV-HL patientsBack to article page